Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients

Diabetes Care - United States
doi 10.2337/dc11-1829
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

A Risk Stratification Tool for Screening for Diabetic Retinopathy Among Type 2 Diabetic Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Impact of Glycemic Traits, Type 2 Diabetes and Metformin Use on Breast and Prostate Cancer Risk: A Mendelian Randomization Study

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2019English

Monotherapy With Metformin Versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Effect of Repetitive Education on Cognitive-Social Factors Among Type 2 Diabetic Patients

International Journal of Research in Medical Sciences
2017English

The Impact of Metformin Use on the Risk of Prostate Cancer After Prostate Biopsy in Patients With High Grade Intraepithelial Neoplasia

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2018English

Effect of Age and Socio-Economic Status on Compliance Among Type 2 Diabetic Patients

Current Research in Diabetes & Obesity Journal
2018English

Correlation of Vit B12 Levels With Metformin Usage Among Type 2 Diabetic Patients in a Tertiary Care Hospital

International Journal of Advances in Medicine
2018English

Glimepiride as Add-On Therapy in Type 2 Diabetic Patients With Metformin Monotherapy: A Real-Life Study From Egypt

The Medical Journal of Cairo University
2018English

Is Statin Use Associated With Prostate Cancer Aggressiveness?

BJU International
Urology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy